BioMimetix JV
Phase 2Develops small molecule therapeutics targeting oxidative stress in oncology and inflammatory diseases.
Founded
2013
Focus
Small Molecules
About
Develops small molecule therapeutics targeting oxidative stress in oncology and inflammatory diseases.
Pipeline Snapshot
1111 drugs in pipeline
| Drug | Indication | Stage |
|---|---|---|
| BMX-010 + Placebo | Psoriasis | Phase 2 |
| BMX-010 + Placebo | Atopic Dermatitis | Phase 2 |
| BMX-010 | Rosacea | Phase 2 |
| BMX-001 | Rectal Cancer | Phase 2 |
| BMX-001 + Cisplatin | Head and Neck Cancer | Phase 2 |
Funding History
13Total raised: $10.5M
Grant$2KNCIMay 17, 2022
Grant$600KNCIDec 20, 2021
Grant$2MNCIAug 9, 2021
Grant$400KNCIFeb 12, 2021
Company Info
TypePrivate
Founded2013
LocationWestminster, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile